097 | Revolutionary research breaks the frontline against HIV and cancer

by • September 18, 2018 • Feature Slider, Feature-Home, Featured-Slides-Home, PodcastComments Off on 097 | Revolutionary research breaks the frontline against HIV and cancer140

Welcome to another episode of Biotechnology Focus radio!

This week there has been some revolutionary research in HIV and natural killer cells. FACIT – the Fight Against Cancer Innovation Trust – has invested in three novel cancer therapeutic discoveries, and Oncolytics Biotech enters a clinical collaboration to combat breast cancer.

Keep listening to find out more details!

 

ADVANCING HIV RESEARCH THROUGH “DATING” OF DORMANT STRAINS

REVOLUTIONARY IMMUNOTHERAPY RESEARCH WAGES WAR ON CANCER 

Dr. Michele Ardolino (Photo Credit: uOttawa)

FACIT SELECTS THREE NOVEL CANCER THERAPEUTIC DISCOVERIES TO RECEIVE CAPITAL

ONCOLYTICS BIOTECH ENTERS INTO A CLINICAL COLLABORATION WITH SOLTI TO COMBAT BREAST CANCER 

Comments are closed.